PDF herunterladen
Drug Res (Stuttg) 2014; 64(4): 203-207
DOI: 10.1055/s-0033-1355336
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Micro-Suspension Coating Method: A New Approach in Formulation and Development of Controlled Porosity Osmotic Pump Systems

K. Adibkia
1   Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
,
J. Hanaee
2   School of Life Sciences, Bradford, United Kingdom
,
S. Ghanbarzadeh
1   Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
,
R. Bahrami
1   Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
,
J. Shokri
1   Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
3   Dermatology & Dermopharmacy Research Team, Tabriz University of Medical Sciences, Tabriz, Iran
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 23. Juli 2013

accepted 20. August 2013

Publikationsdatum:
11. September 2013 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Purpose:

The aim of this study was to design and evaluate diltiazem hydrochloride controlled porosity osmotic pump (CPOP) system employing a new coating technique named the micro suspension coating method.

Method:

In this method the fast dissolving pore formers were suspended in polymeric coating solution as micronized particles. Cellulose acetate and dextrose were used as film former polymer and pore former, respectively. 4 comparative parameters i. e., D24h (cumulative release percent after 24 h), Devzero (mean percent deviation of drug release from zero order kinetic), tL (lag time of the drug release) and RSQzero were used to assess various formulations.

Results:

The results showed a significant increase of D24h due to the decrease in the thickness of the semipermeable membrane (SPM) and increase of the sucrose concentration (P<0.05). An inverse relationship was seen between sucrose amounts and drug release lag times of the formulations. In addition, lag time was significantly reduced following addition of tween 80 to SPM formulation (P<0.05). Results of scanning electron microscopy studies exhibited formation of pores in the membrane from where the drug release occurred.

Conclusion:

Micro suspension coating method was found to be a novel and promising method to formulate CPOP system of diltiazem hydrochloride.

Key words

drug delivery - drug research - pharmaceutics
 

  • References

  • 1 Speers M, Bonnano C. Economic aspects of controlled drug delivery: Encyclopedia of Controlled Drug.
    PubMedGoogle Scholar
  • 2 Verma RK, Kaushal AM, Garg S. Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology. Int J Pharm 2003; 263: 9-24
    CrossrefPubMedGoogle Scholar
  • 3 Makhija SN, Vavia PR. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine: I. Cellulose acetate as a semipermeable membrane. J Controlled Release 2003; 89: 5-18
    CrossrefPubMedGoogle Scholar
  • 4 Liu L, Ku J, Khang G et al. Nifedipine controlled delivery by sandwiched osmotic tablet system. J Controlled Release 2000; 68: 145-156
    CrossrefPubMedGoogle Scholar
  • 5 Prabakaran D, Singh P, Kanaujia P et al. Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps. Int J Pharm 2003; 259: 173-179
    CrossrefPubMedGoogle Scholar
  • 6 Verma RK, Krishna DM, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Controlled Release 2002; 79: 7-27
    CrossrefPubMedGoogle Scholar
  • 7 Santus G, Baker RW. Osmotic drug delivery: a review of the patent literature. J Controlled Release 1995; 35: 1-21
    CrossrefPubMedGoogle Scholar
  • 8 Theeuwes F. Osmotic system for delivering selected beneficial agents having varying degrees of solubility. 1998
    PubMedGoogle Scholar
  • 9 Cortese R, Theeuwes F. Osmotic device with hydrogel driving member. 1982; 725
    PubMedGoogle Scholar
  • 10 Wong PSL, Barclay BL, Deters JC et al. Osmotic device for administering certain drugs. 1988; 989
    PubMedGoogle Scholar
  • 11 Zentner GM, McClelland GA, Sutton SC. Controlled porosity solubility- and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride. J Controlled Release 1991; 16: 237-243
    CrossrefPubMedGoogle Scholar
  • 12 Zentner GM, Rork GS, Himmelstein KJ. The controlled porosity osmotic pump. J Controlled Release 1985; 1: 269-282
    CrossrefPubMedGoogle Scholar
  • 13 Thombre AG, Zentner GM, Himmelstein KI. Mechanism of water transport in controlled porosity osmotic devices. J Membr Sci 1989; 40: 279-310
    CrossrefPubMedGoogle Scholar
  • 14 Thombre AG, DeNoto AR, Gibbes DC. Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients. J Controlled Release 1999; 60: 333-341
    CrossrefPubMedGoogle Scholar
  • 15 Thombre AG, Cardinal JR, DeNoto AR et al. Asymmetric membrane capsules for osmotic drug delivery: I. Development of a manufacturing process. J Controlled Release 1999; 57: 55-64
    CrossrefPubMedGoogle Scholar
  • 16 Thombre AG, Cardinal JR, DeNoto AR et al. Asymmetric membrane capsules for osmotic drug delivery: II. In vitro and in vivo drug release performance. J Controlled Release 1999; 57: 65-73
    CrossrefPubMedGoogle Scholar
  • 17 Herbig SM, Cardinal JR, Kosrsmeyer RW et al. Asymmetric membrane tablet coating for osmotic drug delivery. J Controlled Release 1955; 35: 127-136
    PubMedGoogle Scholar
  • 18 Thombre AG, Appel LE, Chidlaw MB et al. Osmotic drug delivery using swellable-core technology. J Controlled Release 2004; 94: 75-89
    CrossrefPubMedGoogle Scholar
  • 19 Shokri J, Hanaee J, Adibkia K et al. Formulation of Nifedipine osmotic pump and evaluation of drug release from prepared formulations. Pharmaceutical Sciences 2003; 2: 75-85
    PubMedGoogle Scholar
  • 20 Ozdemir N, Sahin J. Design of a controlled release osmotic pump system of ibuprofen. Int J Pharm 1997; 158: 91-97
    CrossrefPubMedGoogle Scholar
  • 21 Shokri J, Ahmadi P, Rashidi P et al. Swellable elementary osmotic pump (SEOP): An effective device for delivery of poorly water-soluble drugs. Eur J Pharm Biopharm 2008; 68: 289-297
    CrossrefPubMedGoogle Scholar
  • 22 Shokri MH, Arami Z, Shokri J. Evaluation of formulation related parameters on the release of gliclazide from controlled porosity osmotic pump system. Pharmaceutical Sciences 2011; 16: 249-260
    PubMedGoogle Scholar
  • 23 Shokri J, Nokhodchi A, Dashbolaghi A et al. The effect of surfactants on the skin penetration of diazepam. International Journal of Pharmaceutics 2001; 228: 99-107
    CrossrefPubMedGoogle Scholar